Clinical trial
Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland…
NCT00137475 · AHS Cancer Control Alberta, Other · Completed
Key facts
| NCT number | NCT00137475 |
|---|---|
| Title | Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function |
| Official title | A Phase I/II Feasibility/Efficacy Study Using Intensity-Modulated Radiation Therapy in Head and Neck (H&N) Cancer Patients to Permit Sparing of Parotid Gland Function |
| Lead sponsor | AHS Cancer Control Alberta, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Procedure |
| Interventions | Intensity-Modulated Radiation Therapy |
| Enrollment | 130 |
| Start date | Feb 1, 2002 |
| Primary completion | Aug 1, 2012 |
| Completion | Aug 1, 2012 |
| First posted | Aug 30, 2005 |
| Last update posted | Feb 26, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: